Safety and tolerability of the lidocaine patch 5%, a targeted peripheral analgesic: A review of the literature
Gammaitoni AR, Alvarez NA, Galer BS. Safety and tolerability of the lidocaine patch 5%, a targeted peripheral analgesic: a review of the literature. J Clin Pharmacol 2003;43:111-117.
Lidocaine patch 5% and its positive impact on pain qualities in osteoarthritis: Results of a pilot 2-week, open-label study using the neuropathic pain scale
Gammaitoni AR, Galer BS, Bradley S, et al. Lidocaine patch 5% and its positive impact on pain qualities in osteoarthritis: results of a pilot 2-week, open-label study using the neuropathic pain scale. Curr Med Res Opin 2004;20:13-19.
Weiland L, Croubels S, Baert K, et al. Pharmacokinetics of a lidocaine patch 5% in dogs. J Vet Med, Series A, 2006;53:34-39.
Weiland L, Croubels S, Baert K, et al. Pharmacokinetics of a lidocaine patch 5% in dogs. J Vet Med, Series A, 2006;53:34-39.
6
13444273001
Effect of lidocaine on the minimum alveolar concentration of isoflurane in dogs
Valverde A, Doherty TJ, Hernandez J, et al. Effect of lidocaine on the minimum alveolar concentration of isoflurane in dogs. Vet Anaesth Analg 2004;31:264-271.
Determination of lidocaine concentrations producing therapeutic and toxic effects in dogs
Wilcke JR, Davis LE, Neff-Davis CA. Determination of lidocaine concentrations producing therapeutic and toxic effects in dogs. J Vet Pharmacol Therapeut 1983;6:105-111.